← FDA DRUG APPROVALS

FDA ANDA · ANDA086277

TRIAMCINOLONE ACETONIDE

Sponsor: SUN PHARMA CANADA

APPLICATION
ANDA086277
TYPE
ANDA
ORIGINAL APPROVAL
1979-04-10
LATEST ACTION
1993-04-08
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued

Products

TRIAMCINOLONE ACETONIDEDiscontinued
TRIAMCINOLONE ACETONIDE 0.025% · CREAM · TOPICAL

Approval history

1993-04-08Labeling · Supplement 45AP
1992-11-16Labeling · Supplement 44AP
1991-07-09Labeling · Supplement 42AP
1991-04-15Manufacturing (CMC) · Supplement 37AP
1990-11-16Labeling · Supplement 41AP
1990-01-03Manufacturing (CMC) · Supplement 36AP
1989-12-12Labeling · Supplement 39AP
1989-11-21Labeling · Supplement 38AP
1989-02-16Labeling · Supplement 35AP
1988-11-01Manufacturing (CMC) · Supplement 30AP
1988-04-14Labeling · Supplement 31AP
1988-04-14Labeling · Supplement 48AP
1986-10-07Manufacturing (CMC) · Supplement 25AP
1985-12-03Manufacturing (CMC) · Supplement 22AP
1985-01-14Manufacturing (CMC) · Supplement 17AP
1985-01-14Manufacturing (CMC) · Supplement 16AP
1984-11-20Manufacturing (CMC) · Supplement 18AP
1984-06-12Manufacturing (CMC) · Supplement 14AP
1983-07-07Manufacturing (CMC) · Supplement 13AP
1983-06-09Manufacturing (CMC) · Supplement 12AP
1982-05-12Manufacturing (CMC) · Supplement 10AP
1982-04-30Manufacturing (CMC) · Supplement 9AP
1979-04-10OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →